-
Mashup Score: 0Captcha - 3 year(s) ago
checkrare.com is protected by Imunify360 We have noticed an unusual activity from your IP 18.224.110.20 and blocked access to this website. …
Source: CheckRare.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Management of IgA Nephropathy - 3 year(s) ago
Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the current standard of care for immunoglobulin A (IgA) nephropathy.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Management of IgA Nephropathy - 3 year(s) ago
Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the current standard of care for immunoglobulin A (IgA) nephropathy.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Early Signs and Symptoms of IgA Nephropathy - 3 year(s) ago
Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the patient population for immunoglobulin A (IgA) nephropathy.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Management of IgA Nephropathy - 3 year(s) ago
Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the current standard of care for immunoglobulin A (IgA) nephropathy.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Early Signs and Symptoms of IgA Nephropathy - 3 year(s) ago
Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the patient population for immunoglobulin A (IgA) nephropathy.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1BK virus infection: an update on diagnosis and treatment - 3 year(s) ago
Abstract. BK virus, first isolated in 1971, is a significant risk factor for renal transplant dysfunction and allograft loss. Unfortunately, treatment options f
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Management of IgA Nephropathy - 3 year(s) ago
Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the current standard of care for immunoglobulin A (IgA) nephropathy.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Cassiano Augusto, MD, on Renal Manifestations of Fabry Disease - 3 year(s) ago
In this Q&A, Cassiano Augusto, MD, answers our questions about his team’s recent narrative review examining Fabry disease nephropathy.
Source: Consultant 360Categories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Epigenetics of Diabetic Nephropathy: From Biology to Therapeutics - European Medical Journal - 3 year(s) ago
Diabetic nephropathy (DN) is a lethal microvascular complication associated with Type 1 and Type 2 diabetes mellitus, and is the leading…
Source: European Medical JournalCategories: Latest Headlines, NephrologyTweet
Richard Lafayette, MD, FACP, from Stanford Medicine (@StanfordMed), describes the patient population for #ImmunoglobulinA (#IgA) #nephropathy. https://t.co/4idV6CAaEz The IGA Nephropathy Foundation of America @IGANFoundation IGA Nephropathy Foundation